Vitamin K2 Market Size & Share 2025 - 2034

Vitamin K2 Market Size

The global vitamin K2 market was estimated at USD 203.4 million in 2024. The market is expected to grow from USD 228.7 million in 2025 to USD 708.7 million in 2034, at a CAGR of 13.4%. The increasing prevalence of chronic diseases such as heart related problems, osteoporosis, cardiovascular disease and cancer is stimulating the market growth.

For example, as per the report by American Heart Association (AHA) over 600,000 Americans experience a heart attack each year, and approximately 610,000 experience a new or recurrent stroke. Moreover, the increasing awareness among consumers towards health benefits associated with vitamin K2, particularly for bone and cardiovascular health led to a greater demand for vitamin K2 supplements, that contribute the market growth. According to NIH, the growing prevalence of unhealthy food consumption in developed countries has resulted in decrease in levels of vitamin K especially vitamin K2 amongst parents and offsprings resulting in serious complications.
 

Additionally, the increasing bone related health issues is rising that results in higher demand of vitamin K2. Also, the increase in number of people suffering from decreasing bone density such as osteoporosis accelerates the market growth. For instance, according to International Osteoporosis Foundation, 37 million fragility fractures occur in people older than 55 age annually, that denotes 70 fractures per minute.
 

The global trend toward healthier lifestyles has significantly increased the demand for vitamin K2. This shift reflects a proactive approach to personal wellness, with individuals aiming to improve their diets and supplement intake. As awareness of the benefits of targeted nutritional support grows, the vitamin K2 market is expected to expand throughout the forecast period. For instance, approximately 59 million Americans regularly use vitamins or supplements, spending an average of USD 510 per year.
 

Moreover, the rising incidence of vitamin K deficiency bleeding (VKDB) in infants is further driving market growth. According to the CDC, early and classical forms of VKDB occur in approximately 1 in 60 to 1 in 250 infants, respectively. Additionally, infants who do not receive the recommended vitamin K injection at birth are at a higher risk of developing late-onset VKDB. This growing concern continues to boost the demand for vitamin K2 supplements.
 

Government is taking various initiatives focusing on the increasing demand for vitamins and minerals by providing easy access for the citizens. For instance, in December 2024, Food Standards Australia New Zealand (FSANZ) has published an application for the allowance of vitamin K2 in special medical food that makes people experience a healthy food intake diet that includes vitamin K2. 
 

Vitamin K2 is also known as menaquinone which is known as fatty soluble vitamins that help body produce prothrombin contributes to bone metabolism and blood clotting. Vitamin K2 fulfil the rising demand for bone and joint health supplements by improving calcium intake and bone density. Moreover, it helps by preventing cardiovascular diseases by avoiding the calcium build up in arteries.
 

Vitamin K2 Market Trends

• The global market for vitamin K2 is expected to witness growth during the forecast period owing to the growing awareness about bone and cardiovascular health. The industry sees a significant growth, with the recent approval of innovative products that are designed to cater the health-conscious consumers. For example, Kappa Bioscience and partners launched seven new K2VITAL white-label vitamin K2 products. This innovation improved the efficacy and appeal of vitamin K2 products, attracting a broader consumer base. 
   
• Moreover, increasing preference for personalized vitamin and nutrition, where individual profiling that includes weight, height and other body conditions are utilised to prepare a customised supplement, drives the growth of the market. Bioniq is a personalized nutrition company that utilizes AI-powered technology to create custom supplement plans based on an individual's unique health profile, including their genetics and lifestyle. It offers tailored supplement recommendations, consultations, and educational resources to promote overall health and wellness.
   
• Additionally, the increase in aging population coupled with growing prevalence of cardiovascular diseases, raises the demand for Vitamin K2, that contribute the market growth. According to WHO, the world’s population over age 60 years will nearly double from 12% to 22% till 2050.
   
• Also, the increasing demand for natural and organic products are influencing the vitamin K2 market. Consumers prefer fermented plant-based sources such as natto as it provides more potential health benefits. This trend helps the market boost for chemical-free and organic alternatives.
   
• Lastly, the rising cases of osteoporosis results in increasing focus on bone and cardiovascular health further increases the demand for vitamin K2. The increasing trend of preventive health has resulted in advancing of new combination of health products such as vitamin K2 along with D3 and calcium may provide a more positive result.
   

Trump Administration Tariffs

• The Trump administrations tariffs on imports from other countries including China, such as pharmaceutical ingredients and chemical compounds will raise the cost of raw materials used in vitamin K2 production. These tariffs may also disrupt supply chains, as many vitamin K2 manufacturers rely on Chinese suppliers for affordable intermediates and production equipment.
   
• As a result of these tariffs, companies in the vitamin K2 market may need to reassess their sourcing and manufacturing strategies to reduce reliance on Chinese suppliers. This could prompt a shift toward sourcing raw materials and equipment from alternative regions such as India, Vietnam, or Eastern Europe.
   
• In the short term, the industry could face challenges such as delays in ingredient availability, increased production costs due to supplier diversification, and possible interruptions in technical and post-sale support for manufacturing equipment and quality control tools.
   

Vitamin K2 Market Analysis

Based on product type, the global market is bifurcated into short chain (MK-4) and long chain (MK-7). The long chain segment dominated the market in 2024 and was valued at USD 120.8 million in 2023 growing from USD 106 million in 2022.
 

• The superior bioavailability and longer half-life in the human body of MK-7 ensuring benefits for cardiovascular and bone health. This stimulates the market demand as healthcare professionals recommends the MK-7vitamin K2 products.
   
• The increasing prevalence of cardiovascular diseases especially amongst elder population has gained importance for preventive healthcare. For instance, MK-7 helps reduce arterial calcification by activation of matrix Gla-protein that avoids the development of calcium build up in blood vessels.
   
• Moreover, the increasing research and development activities leads to growing number of clinical trials for MK-7 has helped improve bone density and reducing fracture risks has increased the market demand and expanding the need of the natural and organic vitamin K2.

Learn more about the key segments shaping this market

Download Free PDF

Based on dosage form, the global vitamin K2 market is divided into capsules, tablets, drops and other dosage form. The capsules segment accounted for the highest market share of 52.5% in 2024 and is anticipated to witness growth at a CAGR of 13.5% during the analysis period.
 

• The higher flexibility in formulation of capsules, stimulate the market growth. Capsules are known for their better absorption and vast range of sizes, providing the manufacturers numerous choices.
   
• Soft gel formulations offer enhanced bioavailability of vitamins and fatty acids, significantly improving nutrient absorption and patient compliance. The U.S. FDA also recommends soft gel capsules due to their superior bioavailability, which ensures more efficient delivery and absorption of active ingredients.
   
• Additionally, other dosage forms such as powders or liquids have proven less effective than capsules, particularly in supporting prostate health a major concern among older men.
   

Based on indication, the global vitamin K2 market is divided bone health, heart health, blood clotting and other indications. The bone health segment dominated the market with USD 92.5 million in 2024 and is anticipated to reach USD 317.9 million by 2034, growing with a significant CAGR of 13.2% during the analysis period.
 

• The rising number of osteoporosis cases has raised awareness among elderly men about the need for vitamin K2 supplements. This insufficiency may also result in muscle weakness. As people surpass the age of 30, vitamin K2 becomes essential for preserving bone density and enhance calcification, thereby enhancing the market. As per NIH, older people experience vitamin K2 deficiency, which leads to osteoporosis and muscle weakness.
   
• The rising incidence of bone health issues among the elderly population is driving market growth. According to the World Health Organization, one in six people worldwide will be over the age of 60 by 2030, highlighting the growing demand for bone health solutions in this age group.
   
• The rising trend of weight gain among middle-aged people has sparked worries regarding health and well-being. This move towards poor dietary choices has raises the demand for weight loss supplements that spurred market growth.
   

Based on distribution channels, the global vitamin K2 market is divided into offline and online. The offline segment dominated the market in 2024 and is anticipated to reach USD 498.4 million by 2034.
 

• The growing demand of vitamin K2 recommended by healthcare professionals for bone health, heart health and various health issues has led to an upsurge in offline supplement sales. For example, as reported by Chemkart, in 2023, 80% of their income came from offline sales. This trend emphasizes the increasing dependence on healthcare experts to assist consumers in choosing suitable vitamins and minerals.
   
• Moreover, the increasing inclination towards in-store shopping is stimulated by the hands-on experience of physical retail and the presence of informed personnel, offering customers confidence in their purchases. For instance, over 43% of British consumers report that they typically purchase health and beauty products from physical retail stores.
   
• This trend underscores the importance of personalized support and the ability to explore products prior to buying, thus aiding the ongoing success of physical retail in the health and wellness sector.

In 2024, the U.S. vitamin K2 market holds a dominant position in the North American market, valued at USD 76.2 million.
 

• The rising awareness of vitamin K2 role for risk reduction of osteoporosis and heart diseases contributes to the growing demand of the market.
   
• Moreover, the growing prevalence of chronic diseases such as osteoporosis and cardiovascular diseases amongst the aging population is contributing to the growing market. For instance, CDC mentioned 60% Americans suffer from at least one chronic disease with the need of vitamin K2 preventing arterial calcification and increase bone health.
   
• Moreover, government initiatives regarding awareness of vitamin K2 for good bone health is stimulating the market growth especially focusing on elderly consumers who are more susceptible to chronic diseases.
   
• Additionally, the online retailing sector is boosting the market which provides wide range of products available throughout the platform additionally direct e-commerce stores helps easy access to the consumer.
   

Germany vitamin K2 market dominates the European market, showcasing strong growth potential.
 

• The country leads the European market, driven by the rising prevalence of chronic diseases. Vitamin K2 plays a vital role in regulating calcium distribution in the body and preventing arterial calcification, making it increasingly important for managing long-term health conditions.
   
• The easy availability of vitamin K2 supplements through online platforms is stimulating the market expansion. The growing use of e-commerce for vitamins and easy availability has made it easy for Germans to access high quality vitamin K2 products globally. For instance, well-known German pharmacies such as DM and Rossmann ensure steady market presence for the vitamins and minerals.
   
• The government and healthcare organizations are proactive in promoting vitamins for maintaining the bone and cardiovascular health.
   
• Numerous public health campaigns have contributed to raising awareness about the importance of vitamins for maintaining good health. According to Statista, in 2023, 60% of Germans reported consuming vitamins, followed by minerals and proteins. Additionally, Gnosis by Lesaffre highlighted the benefits of vitamin K2 MenaQ7 for bone and heart health during the Denk Ingredients Annual Symposium in Munich, Germany, further promoting its relevance in preventive healthcare.
   

China vitamin K2 market is emerging as the fastest-growing country in the Asia Pacific, market.
 

• Rapid expansion of China market due to spreading awareness on bone health and cardiovascular wellness is increasing the demand with a rapid growth and emerging as fastest growing segment in Asia-Pacific region.
   
• The aging population of the country and the rising middle class play a crucial role in stimulating market growth.
   
• The country's increasing health consciousness is driving demand for vitamins and minerals in the over the counter (OTC) drugs segment. As part of this trend, China’s "Healthy China 2030" initiative aims to enhance public health by promoting physical activity and nutritional awareness.
   
• Additionally, China’s large working-age population estimated at approximately 982.9 million people in 2023, according to Statista particularly in urban areas, is placing greater emphasis on the intake of vitamins and minerals to support bone health, cardiovascular function, and blood clotting. This shift is contributing to the growth of the market.
   

Brazil vitamin K2 leads the Latin American vitamin K2 market, exhibiting remarkable growth during the analysis period.
 

• The vitamin market in Brazil is expanding due to increasing concerns of bones, circulation and general health. According to the Brazilian Society of Endocrinology and Metabolism (SBEM), as there is increase in elderly population ages, there is a growing need for preventive health measures along with K2 supplements emerging as an effective for managing bone health and cardiovascular risks.
   
• The country has a large population of young people in Latin America with increasing awareness of fitness culture and use of vitamins and minerals that include vitamin K2, therefore expanding the demand for the vitamin K2 for improving bone health.
   
• The Brazilian government National Health Surveillance Agency (ANVISA) spreads awareness for vitamins and minerals, which ensures the safety and efficacy of vitamin K2 products. Government organises wellness campaigns and health programs have helped increase consumer awareness of the benefits of vitamin K2.
   

Saudi Arabia is expected to experience the highest growth rate in the Middle East and Africa vitamin K2 market in 2024.
 

• Saudi Arabia Vision 2030 program has taken a shift towards preventive health. People are adopting to taking vitamins and minerals before the occurrence of any disease.
   
• Saudi Arabia focuses on healthy lifestyle that stimulates the demand for the market. Increasing number of gyms, yoga centres and fitness studio has significantly changed the perspective of men towards their physical well-being.
   
• The government invests in healthcare. Vision 2030 suggests allocating USD 1.5 billion towards health information technology and telemedicine. By 2030, more than USD 65 billion will be invested in healthcare sector.
   

Vitamin K2 Market Share

The top six players—NattoPharma, Kappa Bioscience (Balchem Corporation), NOW Foods, Gnosis, DSM Nutritional Products, and MaryRuth Organics account for approximately 65% – 75% of the market share. These companies employ various strategies such as acquisitions, business expansion, and product launches to strengthen their market presence. For example, in June 2022, Balchem announced an agreement to acquire Kappa Bioscience, a company well known for its expertise in vitamin K2. This strategic move aligns with Balchem’s vision of advancing health and wellness.
 

Kappa Bioscience is dedicated to developing high-quality solutions focused on vitamin K2 to enhance quality of life. These companies are actively adopting multi-pronged approaches to meet the growing demand for vitamin K2. Moreover, the market remains highly fragmented, with numerous players operating within it, creating opportunities for further expansion. As a result, leading companies continue to implement key strategies to drive market growth.
 

Vitamin K2 Market Companies

The company profile section includes companies that have commercial products available in the market. Prominent players operating in the market are as mentioned below:

• Amway Nutrilite
• Carlyle Nutritionals
• Doctor's Best
• Health Veda Organics
• Innovix labs
• Kappa Biosciences (Balchem Corporation)
• Mary Ruth Organics
• NattoPharma
• Pharma Cure Laboratories
• Phi Naturals
• Smarter Vitamins
• Vlado's Himalayan Organics
• WOW Lifesciences
• Zenith Nutrition
   

Many leading players are focusing on expansion of their existing business and strategic collaboration by establishing new products in the market. For example, in July 2023, GF Fermentech entered partnership with Kregliner & Barentz a global bio-health distribution company for enabling the visibility of vitamin K2 products. This collaboration expands the sales, operations and brand awareness for good health. The company’s focus on research and development fulfils the requirement for market.
 

Vitamin K2 Industry News

• In November 2024, Balchem launched a three-in-one concept with the formulation of vitamin K2, vitamin D3, and magnesium bisglycinate that provided health benefits and efficacy for immune, cardiovascular and bone health. The product had a positive feedback report for the initial surveys conducted in North America and Europe. This helped the company expand its sales in Europe and North America.
   
• In March 2024, Gnosis and SunWay Biotech by Lefsaffre launched MenaQ7 Metabolic. It is a blend of vitamin K2 and stalin-free red yeast rice fermentate, Ankascin 568-R which is designed to support heart and bone health. This product launch helped the company accomplish new innovative products.
   
•  In April 2022, Gf Fermentech which is a subsidiary of Genofocus introduced vitamin K2 capsule named MediQ7 Pure, nautral source from Bacillus subtilis natto. This product boosts 96% menaquinone-7. This helped the company expand its product offerings.
   

The vitamin K2 market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021–2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Short chain (MK-4)
• Long chain (MK-7)

Market, By Dosage Form

• Capsules
• Tablets
• Drops
• Other dosage form

Market, By Indication

• Bone health
• Heart health
• Blood clotting
• Other indications

Market, By Distribution Channel

• Offline 
  • Pharmacies and drug stores
  • Supermarkets/hypermarkets
  • Other offline stores 
• Online

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE